Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating activities:
Net loss	$ (24,774)	$ (44,306)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,046	4,886
Goodwill impairment	11,052	23,989
Non-cash lease expense	2	(227)
Change in fair value of warrant liabilities	(137)	(448)
Amortization of debt discount and financing issuance costs	20	0
Provision for credit losses	172	0
Stock based compensation	2,828	3,520
Gain on sale of ViewSpot, net	(1,287)	0
Gain on license of patents, net	0	(198)
Changes in operating accounts:
Accounts receivable	2,972	4,506
Prepaid expenses and other assets	382	315
Accounts payable, accrued, and other liabilities	(283)	(1,405)
Net cash used in operating activities	(5,007)	(9,368)
Investing activities:
Capital expenditures, net	(52)	(17)
Proceeds from sale of ViewSpot, net	1,287	0
Proceeds from license of patents, net	0	198
Net cash provided by investing activities	1,235	181
Financing activities:
Issuance of common stock and warrants in connection with common stock offering, net of issuance costs	966	3,351
Issuance of notes payable and warrants	1,233	0
Proceeds from financing arrangements	933	1,044
Repayments of financing arrangements	(776)	(829)
Other financing activities	2	5
Net cash provided by financing activities	2,358	3,571
Net decrease in cash and cash equivalents	(1,414)	(5,616)
Cash and cash equivalents, beginning of period	2,808	7,125
Cash and cash equivalents, end of period	1,394	1,509
Supplemental disclosure of non-cash financing activities:
Deemed dividend	$ 635	$ (0)